Two-channel IV-PCA With Dexmedetomidine
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age20+
SponsorKorea University Guro Hospital
About this trial
Dexmedetomidine was administered in the 'selector' channel and fentanyl in the 'basic \& bolus' channel of dual channel intravenous patient-controlled analgesia (IV-PCA) and the amount of opioid consumption was compared. In addition, intensity of pain, postoperative nausea/vomiting, and postoperative delirium was evaluated.
Eligibility criteria
Qualifiers
Patients who was scheduled for laparoscopic major abdominal surgery (Gastrectomy, Hepatectomy, Colectomy, Pancreatectomy) under general anesthesia
Aged ≥ 20 years old
Disqualifiers
Body mass index ≥35 kg/m2
American Society of Anesthesiologists physical status > 3
Severe cardiovascular disorder
Severe liver or renal dysfunction
Trial design
Treatments tested in this trial
- Dexmedetomidine
- Control
Treatment groups
110 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov